Can the Profitability of Medical Enterprises Be Improved After Joining China's Centralized Drug Procurement? A Difference-in-Difference Design

This paper explores the impact of joining centralized drug procurement of China on the profitability of medical enterprises by the difference-in-difference (DID) model. When centralized procurement cannot bring enough cost savings to enterprises, the price competition caused by centralized procureme...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Yu-Fei, Lu, Jin, Bai, Bing, Zhao, Han-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843945/
https://www.ncbi.nlm.nih.gov/pubmed/35178375
http://dx.doi.org/10.3389/fpubh.2021.809453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843945/
https://www.ncbi.nlm.nih.gov/pubmed/35178375
http://dx.doi.org/10.3389/fpubh.2021.809453

Ejemplares similares